期刊文献+

神经精神狼疮25例临床分析 被引量:3

下载PDF
导出
摘要 神经精神狼疮(NPLE)是系统性红斑狼疮(SLE)累及中枢神经系统所致的神经精神表现,其发生率高达14%~75%[1],且可出现在疾病的各个阶段.重症NPLE 有较高的病死率和致残率,早期诊断和适当治疗尤为重要.现我们将观察到的25 例NPLE患者的临床状况作一回顾性分析,现报告如下.
出处 《中国药物与临床》 CAS 2011年第5期577-578,共2页 Chinese Remedies & Clinics
  • 相关文献

参考文献11

  • 1Scolding NJ,Joseph FG.The neuropathology and pathogenesis of systemic lupus erythematosus.Neuropathol Appl Neurobiol,2002,28(3):173-189.
  • 2Hochberg MC.Updating the American Collage of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1997,40:1725.
  • 3ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature.The American College of Rheumatology nomenclature and case definition for neuropsychiatric lupus syndromes.Arthritis Rheum,1999,42:599-608.
  • 4Lessa B,Santana A,Lima I,et al.Prevalence and classification of headache in patients with systemic lupus erythematosus.Clin Rheumatol,2006,25:850-853.
  • 5周惠琼,冷晓梅,张奉春.神经精神狼疮患者240例的临床特点、治疗及预后分析[J].中华医学杂志,2006,86(11):771-774. 被引量:33
  • 6许杰州,黄林喜,吴贤仁,刘元生,林玲.神经精神狼疮的临床分型及其预后[J].中华风湿病学杂志,2003,7(11):659-662. 被引量:16
  • 7王元,顾越英,鲍春德,陈顺乐,周滟,许建荣,钱可久.神经精神狼疮的诊断和治疗[J].中华风湿病学杂志,2004,8(4):230-233. 被引量:17
  • 8Sannna G,Bertolaccini ML,Cuadrado MJ,et al.Neuropsychiatric manifestation in systemic lupus erythematosus:prevalence and association with antiphospholipid antibodies.Rheumatol,2003,30:985-992.
  • 9Hanly JG,Urowitz MB,Sanchez-Guerrero J,et al.Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus:an international inception cohort study.Arthritis Rheum,2007,56:265-273.
  • 10Cervera R,Khamashta MA,Font J,et al.Morbidity and mortality in SLE during a 10-year period:a comparison of early and late manifestation in a cohort of 1000 patients.Medicine(Baltimore),2003,82(5):299-308.

二级参考文献47

  • 1张奉春,董怡,赵玉华,林禾,姜泉,赵杰.系统性红斑狼疮中枢神经系统病变的诊断及治疗[J].北京医学,1994,16(5):277-280. 被引量:23
  • 2Liang MH, Corzillius M, Bae SC, et al. ACR ad hoc Committee on neuropsychiatric lupus nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum, 1999,42 : 599-608.
  • 3Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index (SLEDAI) for lupus patients.Arthritis Rheum, 1992,35 : 630-640.
  • 4Gladman DD, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum, 1996,39 : 363-369.
  • 5Isshi K, Hirohata S. Association of anti -ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum, 1996,39:1483-1490.
  • 6Arman S, Wilmer L, Sibbitt J, et al. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke, 1998,29 : 2254-2260.
  • 7Bosma G, Rood M, Zwinderman A, et al. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. Arthritis Rheum, 2000,43 : 48-54.
  • 8Weiner S, Otte A, Sehumacher M, et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythemaatosus : value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis,2000,59:377-385.
  • 9Hay E,Huddy A,Black D,et al. A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus.Ann Rheum Dis, 1994,53:298-303.
  • 10West SG . Neuropsychiatric lupus . Rheum Dis Clin North Am ,1994,20:129-158.

共引文献66

同被引文献19

  • 1周惠琼,冷晓梅,张奉春.神经精神狼疮患者240例的临床特点、治疗及预后分析[J].中华医学杂志,2006,86(11):771-774. 被引量:33
  • 2Hochberg MC.Updating the American Collage of Rheumatology re-vised criteriafor the classification of systemic lupus erythematosus[J].Aethritis Rheum,1997,40:1725.
  • 3ACR AdHoc Committee on Neuropsychiatric Lupus Nomenclature.The American College of Rheumatology nomenclature and case defi-nitions for neuropsychiatric lupus syndromes[J].Arthritis Rheum,1999,42:599-608.
  • 4Goconi M,Castellion G,Padovan M,et al.Recent advances and futureperspective in neuroimaging in neuropsychiatric systemic lupus ery-thematosus[J].Lupus,2004,13(3):149-158.
  • 5Brooks WM,Sibbitt WL Jr,Kornfeld M,et al.The histo-pathologic as-sociates of neurometabolite abnormalities in fatal neuropsychiatric sys-temic lupus erythematosus[J].Arthritis Rheum,2010,62:2055-2063.
  • 6Ben-Ami SD,Blank M,Altman A.The clinical importance of anti-ri-bosomal-P antibodies[J].Harefuah,2010,149:794-810.
  • 7Bertsias GK,Boumpas DT.Pathogenesis,diagnosis and managementof neuropsychiatric SLE manifestations[J].Nat Rev Rheumatol,2010,6:358-367.
  • 8Luyendijk J,Steens SC,Ouwendijk WJ,et al.Neuropsychiatric sys-temic lupus erythematous:lessons learned form magnetic resonanceimaging[J].Arthritis Rheum,2011,63:722-732.
  • 9Ramage Amy E,Fox PT,Brey RL,et al.Neuroimaging evidence ofqhite Matter inflammation in newly diagnosed systemic lupus erythe-matosus[J].Arthritis Rheum,2011,63:3048-3057.
  • 10Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of theSLEDAI:A disease activity index for lupus patients.the committee onprognosis studies in SLE.Arthritis Rheum,1992,35:630-640.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部